fluconazole has been researched along with Diabetes Mellitus in 18 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the treatment of onychomycosis, compliance and drug interactions are important considerations, as diabetic patients frequently take concomitant medications." | 2.45 | Toenail onychomycosis in diabetic patients: issues and management. ( Budihardja, D; Freund, V; Mayser, P, 2009) |
| "She was diagnosed with cryptococcal meningitis in diabetes and had a remarkable response to fluconazole monotherapy." | 1.51 | CRYPTOCOCCAL meningitis in a HIV negative newly diagnosed diabetic patient: a CASE report. ( Chege, P; Owuor, OH, 2019) |
| "Cancer was the most common underlying disease (n = 127, 72." | 1.42 | Epidemiology and prognostic factors of candidemia in elderly patients. ( Lai, CC; Lin, HL; Liu, WL; Tang, HJ, 2015) |
| "He presented with headache, seizures, confusion, fever and left hemiparesis upon hospitalization in 2006 at Hospital São Marcos." | 1.40 | Cerebral aspergillosis in a patient with leprosy and diabetes: a case report. ( Bezerra, GF; da Silva, MA; Filho, WE; Nascimento, AC; Nascimento, Mdo D; Segundo, JB; Viana, GM; Vidal, FC, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Broderick, KL | 1 |
| Peters, CJ | 1 |
| Mazurek, JA | 1 |
| Wald, J | 1 |
| Zhang, RS | 1 |
| Atluri, P | 1 |
| Urgo, K | 1 |
| Goldberg, L | 1 |
| Blumberg, EA | 1 |
| Weikert, BC | 1 |
| Birati, EY | 1 |
| Li, YH | 1 |
| Sun, P | 1 |
| Guo, JC | 1 |
| Owuor, OH | 1 |
| Chege, P | 1 |
| Benedetti, VP | 1 |
| Savi, DC | 1 |
| Aluizio, R | 1 |
| Adamoski, D | 1 |
| Kava, V | 1 |
| Galli-Terasawa, LV | 1 |
| Glienke, C | 1 |
| Sanitá, PV | 1 |
| Mima, EG | 1 |
| Pavarina, AC | 1 |
| Jorge, JH | 1 |
| Machado, AL | 1 |
| Vergani, CE | 1 |
| Tang, HJ | 1 |
| Liu, WL | 1 |
| Lin, HL | 1 |
| Lai, CC | 1 |
| Segundo, JB | 1 |
| da Silva, MA | 1 |
| Filho, WE | 1 |
| Nascimento, AC | 1 |
| Vidal, FC | 1 |
| Bezerra, GF | 1 |
| Viana, GM | 1 |
| Nascimento, Mdo D | 1 |
| Maatouk, I | 1 |
| Hajjar, MA | 1 |
| Moutran, R | 1 |
| Yeung, VA | 1 |
| Azzam, R | 1 |
| Dendle, C | 1 |
| Graham, M | 1 |
| Woolley, IJ | 1 |
| Korman, TM | 1 |
| Mayser, P | 1 |
| Freund, V | 1 |
| Budihardja, D | 1 |
| Khan, ZU | 1 |
| Al-Anezi, AA | 1 |
| Chandy, R | 1 |
| Xu, J | 1 |
| Tanigawa, M | 1 |
| Kimura, M | 1 |
| Ichioka, M | 1 |
| Saito, K | 1 |
| Gonçalves, RH | 1 |
| Miranda, ET | 1 |
| Zaia, JE | 1 |
| Giannini, MJ | 1 |
| Kallel, K | 1 |
| Mejri, H | 1 |
| Belhadj, S | 1 |
| Boussen, N | 1 |
| Kilani, B | 1 |
| Zouiten, F | 1 |
| Ben Abid, H | 1 |
| Zribi, A | 1 |
| Chaker, E | 1 |
| Franco, RC | 1 |
| Gupta, R | 1 |
| Mittal, A | 1 |
| Bhatnagar, LK | 1 |
| Bansal, NK | 1 |
| Abad, S | 1 |
| Moachon, L | 1 |
| Blanche, P | 1 |
| Bavoux, F | 1 |
| Sicard, D | 1 |
| Salmon-Céron, D | 1 |
| Rowe, BR | 1 |
| Thorpe, J | 1 |
| Barnett, A | 1 |
1 review available for fluconazole and Diabetes Mellitus
| Article | Year |
|---|---|
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes | 2009 |
1 trial available for fluconazole and Diabetes Mellitus
| Article | Year |
|---|---|
Safety of fluconazole in women taking oral hypoglycaemic agents.
Topics: Administration, Oral; Aged; Aged, 80 and over; Blood Glucose; Clotrimazole; Diabetes Mellitus; Drug | 1992 |
16 other studies available for fluconazole and Diabetes Mellitus
| Article | Year |
|---|---|
Characteristics and Outcomes of Candidemia in Patients with Durable Left Ventricular Assist Device Support.
Topics: Candidemia; Diabetes Mellitus; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Retrospecti | 2022 |
Clinical Analysis of Diabetic Combined Pulmonary Mucormycosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Female; Flucona | 2017 |
CRYPTOCOCCAL meningitis in a HIV negative newly diagnosed diabetic patient: a CASE report.
Topics: Adult; Antifungal Agents; Cryptococcus neoformans; Diabetes Mellitus; Female; Fluconazole; HIV Seron | 2019 |
ERG11 gene polymorphisms and susceptibility to fluconazole in Candida isolates from diabetic and kidney transplant patients.
Topics: Adult; Aged; Antifungal Agents; Candida; Diabetes Mellitus; DNA, Fungal; Drug Resistance, Fungal; Fe | 2019 |
Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida-associated denture stomatitis with or without diabetes.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis, Oral; Caspofungin; Diabetes Mellitu | 2013 |
Epidemiology and prognostic factors of candidemia in elderly patients.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidemia; Comorbidity; Diabetes Me | 2015 |
Cerebral aspergillosis in a patient with leprosy and diabetes: a case report.
Topics: Amphotericin B; Anticonvulsants; Antifungal Agents; Aspergillus fumigatus; Biopsy; Carbamazepine; Ce | 2014 |
Candida albicans and Streptococcus pyogenes balanitis: diabetes or STI?
Topics: Amoxicillin; Anti-Bacterial Agents; Antifungal Agents; Balanitis; Candida albicans; Candidiasis; Dia | 2015 |
Cryptococcemia in primary HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cry | 2016 |
Disseminated cryptococcosis in an AIDS patient caused by a canavanine-resistant strain of Cryptococcus neoformans var. grubii.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 2003 |
[A case of secondary pulmonary cryptococcosis complicating diabetes mellitus].
Topics: Aged; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Diabetes Complic | 2004 |
Species diversity of yeast in oral colonization of insulin-treated diabetes mellitus patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Diabetes Mellitus; Drug Resistance, F | 2006 |
[Neurologic cryptococcosis: meningitis of the immunosuppressed patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agen | 1999 |
Deep dermatophytosis in a post transplant recipient.
Topics: Antifungal Agents; Dermatomycoses; Diabetes Mellitus; Fluconazole; Humans; Kidney Transplantation; M | 2001 |
Oral hypoglycemics and azoles: an important drug interaction.
Topics: Antifungal Agents; Candidiasis; Diabetes Mellitus; Drug Interactions; Female; Fluconazole; Glyburide | 2001 |
Possible interaction between gliclazide, fluconazole and sulfamethoxazole resulting in severe hypoglycaemia.
Topics: Anti-Infective Agents; Antifungal Agents; Diabetes Complications; Diabetes Mellitus; Drug Interactio | 2001 |